Blood pressure medication recalled for potential ineffectiveness

The FDA recalled 11,460 bottles of chlorthalidone tablets due to potential ineffectiveness from failed dissolution specifications. The affected batches are RISA24001 (100-tablet bottles) and RISB24002 (1,000-tablet bottles), with an expiration date of April 2027. The medication is used to treat high blood pressure and fluid retention from conditions like heart failure, liver disease, kidney disease, or steroid treatments.